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Analysis of chimerism by polymerase chain reaction
amplification of STR or VNTR has become a routine
procedure for the evaluation of engraftment after
allogeneic stem cell transplantation. Knowledge of the
frequency of different STR or VNTR alleles in unrelated
individuals in a population is useful for forensic work.
In the context of HLA identical sibling bone marrow
transplantation the informativeness of these markers
needs to be evaluated. We evaluated five STRs (THO1,
VWA, FES, ACTBP2, and F13A1) and 1 VNTR
(APOB) for informativeness in stem cell transplants from
HLA identical sibling donors. All four markers used
individually allowed us to discriminate 20–56% of the
patient donor pairs. Using a combination of all these
markers along with a polymorphic marker in the b-globin
gene and the sex chromosome specific amelogenin marker,
we were able to discriminate 99% of the patient donor
pairs. We have established an algorithm for evaluating
chimerism following HLA identical sibling donor trans-
plants in the Indian population using molecular markers in
310 patients. Analysis of heterozygote frequencies in
different populations is similar suggesting that this
algorithm can be used universally for transplant centers
to evaluate chimerism following allogeneic bone marrow
transplantation.
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Introduction
Short tandem repeat (STR) or variable number tandem
repeat (VNTR) loci are groups of DNA sequences, which
are highly polymorphic markers and can therefore be used
for identification of an individual. They are used for a
variety of applications including forensic identification,1
phylogenetic reconstruction2 and to monitor chimerism
after allogeneic bone marrow transplantation for early
diagnosis of graft failure or disease relapse. Allelic
frequencies, allelic distribution pattern and level of hetero-
zygosity of certain microsatellite markers has already been
reported in various ethnic groups. A microsatellite locus
used for chimerism analysis must have a different allelic
profile in the patient and donor. Several studies have shown
that the overall informativeness of STRs differs signifi-
cantly between related and unrelated individuals.3 There
are limited data on the informativeness of various VNTRs
or STRs in HLA identical recipient donor pairs. Many
transplant centers use STR kits to monitor chimerism but
these are quite expensive. We screened five STRs namely
FES, THO1, VWA, ACTBP2, and F13A1 and 1 VNTR,
APOB, in order to develop an algorithm of sequential
testing for evaluation of chimerism in a cost effective
manner after allogeneic stem cell transplantation.
Patients and methods
Chimerism was studied retrospectively in 310 hematopoie-
tic stem cell transplants (HSCT) during the period 1993–
2005. All donors were HLA identical siblings or related
family members. Two hundred and ninety five (95%)
patients and donors were studied by polymerase chain
reaction (PCR) for one or more of the polymorphic repeat
sequences given in the Table 1 but for 15 (5%), which
were sex, mismatched only the amelogenin PCR was
performed. The number of patients evaluated with THO1
was 263 (89%), ACTBP2: 265 (90%), FES: 248 (84%)
and VWA: 255 (86%). Combined data on informativeness
of all these four markers was available for 219 patients
(74%). In this study, 293 patients were from India: 120
(39%) from the South, 88 (28%) from the North, 25 (8%)
from the East and 59 (19%) from the West of India.
Seventeen (5%) of the patients were from other countries:
Maldives (n¼ 4), Oman (n¼ 4), Sri Lanka (n¼ 2),
Singapore (n¼ 1), Mauritius (n¼ 1), Pakistan (n¼ 3),
and Bhutan (n¼ 2). A STR/VNTR marker was considered
to be informative if any one of the alleles of the patient is
different from that of the donor. Parents were not
genotyped and therefore a pedigree analysis for these
STR/VNTRs is not possible.
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DNA analysis
DNA was extracted using a standard extraction protocol.
Both patient and donor samples were amplified by PCR
with specific primer pairs for the five STRs.4–7 The marker,
gene, and chromosomal location is given in Table 1. Primer
sequences for the above-mentioned markers are given in
Table 2. Polymerase chain reaction was performed using
standard concentrations of primers (0.3mM) and 2PCR
master mix (ABgenes, Blenheim Road, UK) containing
0.2mM of each dNTPs, 20mM (NH4) 2SO4, 75mM Tris HCl
(pH 8.8 at 251C, 1.5mM MgCl2, 0.01% (v/v) Tween 20 and
1.25U Taq DNA polymerase. Polymerase chain reaction
conditions for ACTBP2, FES, THO1, VWA, and F13A1
markers were initial denaturation at 941C for 5min,
followed by 30 cycles with denaturation at 941C for 40 s
and annealing and extension at 571C for 2min and 721C for
5min, respectively. Polymerase chain reaction products
were analyzed in 10 or 12% polyacrylamide gel. Polymer-
ase chain reaction for APOB marker was performed with
the annealing temperature of 581C for 5min. Amelogenin
PCR for amplifying a region on X and Y chromosome was
performed using 1 buffer, 0.25mM dNTPs, 0.4 mm of each
primers, 0.5 mM of MgCl2 and 1U Amersham Taq
polymerase for a single reaction at an annealing tempera-
ture of 621C for 2min. Polymerase chain reaction products
were analyzed in 2% agarose gel.
Temporal temperature gradient gel electrophoresis. A
fragment of b-globin gene (IVS-II) containing three
intragenic polymorphisms (nucleotide (nt) 16, C/G; nt 74,
G/T; and nt 81, C/T) was amplified by PCR using the
primer sequences8 given in Table 2. Polymerase chain
reaction products were analyzed in 6% polyacrylamide
(acrylamide: bis 37.5:1) gels containing 6mol/l urea in a
temperature gradient. Electrophoresis was carried out at
130V at constant temperature increments of 21C/h on the
D Code TM mutation detection system (Bio-Rad Labora-
tories, Hercules, CA, USA), which has an automatic
thermal regulator that increases temperature gradually
over the length of electrophoresis.
Genescan. Polymerase chain reaction products obtained
using fluorescence labeled primers were mixed with 12ml of
deionized formamide and 0.5ml of Rox 500 size standard
and denatured at 951C for 5min. These samples were
subjected to denaturing capillary gel electrophoresis using
ABI 310 sequencer (Applied Biosystems, Foster city, CA,
USA) Data were analyzed using the Genotyper 2.5
software. The proportion of patient and donor in post-
BMT samples was calculated as previously described.9
Results
All four markers used individually allowed us to discrimi-
nate 44–56% of the patient donor pairs. Of the four
markers, THO1 (56%) and ACTBP2 (53%) were found to
be highly informative, followed by VWA (50%), and FES
(44%). By combining one, two or three markers, we could
discriminate between 68 and 92% of the patient donor
pairs. Informativeness of the markers THO1þVWF,
Table 1 Gene location of different microsatellite and minisatellite markers
Marker Satellite type Gene name Repeat sequences Chromosome location
FES Micro Human c-fes proto-oncogene (ATTT) n 15q25-qter
THO1 Micro Tyrosine hydroxylase gene CATT/(AATG) n 11p15–15.5
VWA Micro von Willebrand antigen gene (TCTA) n 12p12-pter
ACTBP2 Micro Actin, beta pseudogene 2 (AAAG) n 6q14
APOB Mini Apolipoprotein gene TTTTATAATTAATATTTATAAT 2p24–p23
F13A01 Mini Human coagulation factor XIII a subunit gene (AAAG) n 6p24.3–25.1
Table 2 Primer sequences for satellite markers
Marker Primer sequences (Sequences in parenthesis are GC clamps) Fluorochrome label
FES4 F: 50 GGG ATT TCC CTA TGG ATT GG 30 Hex
R: 50 GCG AAA GAA TGA GAC TAC AT 30
THO15 F: 50 GTG GGC TGA AAA GCT CCC GAT TAT 30 FAM
R: 50 GTG ATT CCC ATT GGC CTG TTC CTC 30
ACTBP26 F: 50 AAT CTG GGC GAC AAG AGT GA 30 Hex
R: 50 ACA TCT CCC CTA CCG CTA TA 30
VWA7 F: 50 AGC TAT ATA TAT CTA TTT ATC AT 30 FAM
R: 50 AGA TAC ATA CAT AGA TAT AGG 30
APOB F: 50 GAA ACG GAG AAA TTA TGG AGG G 30 Nil
R: 50 TCC TGA GAT CAA TAA CCT CG 30
F13A15 F: 50 ATG CCA TGC AGA TTA GAA A 30 Hex
R: 50 GAG GTT GCA CTC CAG CCT TT 30
AMG A: 50 CTG ATG GTT GGC CTC AAG CCT GTG 30 Nil
B: 50 TAA AGA GAT TCA TTA ACT TGA CTG 30
C: 50 GCC CAA AGT TAG TAA TTT TAC 30
G-fragment b-globin gene8 F: 50 (GCC CGC CGT CCC GGC CCG ACC CCC GCG CGT CCG GCG CCC G) CTG GGC
ATG TGG AGA CAG AG 30
Nil
R: 50 CAC TGA TGC AAT CAT TCG TC 30
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THO1þVWFþACTBP2, THO1þVWFþACTBP2þ
FES was 79, 87, and 92%, respectively. None of these
markers was informative in 18 patients. APOB was
informative in six of these 18 patients (33%) and for the
whole group it was informative in 40% (52/131).
We have recently added a new marker, F13A1, into
our panel and it was the only informative marker in
one patient. Schematic representation of informativeness
of the STRs/VNTRs used in our cohort is shown in
Figure 1.
Of the remaining 11 patients, two were sex-mismatched
transplants and hence amelogenin PCR was used for
documenting the chimerism status. In the remaining nine
patients, the G-fragment of the b-globin gene was analyzed
by temporal temperature gradient gel electrophoresis
(TTGE) and this allowed us to discriminate two cases.
Thus, the above panel was informative in 98% of the
transplants.
In the seven patients where no informative marker could
be identified, gene scan analysis was useful in five patients.
Thus, this panel of molecular markers was informative for
chimerism analysis in 308 of 310 (99%) allogeneic stem cell
transplants.
There were 166 sex-mismatched transplants and of
these 115 were female to male transplants where the
amelogenin gene PCR is useful for chimerism analysis.
Data on the amelogenin gene PCR were available for 43
of these patients and 24 showed mixed chimerism. In 11
of these 24 patients, analysis with one of the other
STRs showed complete chimerism suggesting that the
amelogenin PCR is a more sensitive indicator of the
chimeric status.
Discussion
Monitoring of chimerism after allogeneic bone marrow
transplantation is important for early diagnosis of graft
failure or disease relapse. Use of DNA-based diagnostics
by STRs is the most suitable method for monitoring
chimerism post transplant.10–15
Published data on sequential testing of chimerism
and informativeness of different markers is limited.16–19
Spyridonidis et al.16 using a combination of five STR
markers (SE 33, THO1, D1S80, YNZ22, and D14S120)
found this panel to be informative in 98% of 165 related
transplants. A similar study from north India has reported
100% informativeness using five STRs (VWA, THO1, FES,
F13, and TPOX).17 A recent study suggests that a similar
panel can be used both for related and unrelated donor
transplants.18 Grubic et al.19 were able to discriminate nine
HLA identical sibling patient donor pairs using a panel of
STRs contaning 6–10 markers. The panel of STR/VNTR
markers used in this study was based on the heterozygosity
value in Caucasoid population. Thiede et al.18 have showed
a linear correlation of heterozygosity with the number of
highly informative STR constellations, which are well
suited for chimerism analysis.
In our panel, THO1 was found to be the most
informative (56%) and F13A1, the least (20%). When
none of these markers in our panel were informative,
polymorphisms in the G-fragment of b-globin gene and the
Y chromosome specific amelogenin marker proved to be
useful.
Table 3 compares the data from north India with this
study17 and Caucasian data which shows some difference in
informativeness of individual markers,18 which can be
attributed to ethnic variations.
Microsatellites are prone to mutation during replication
and this has implications when they are used for paternity
analyses or disease linkage mapping, where a mutation
may lead to false exclusion. Mutation rates have been
found to be different between various loci and among
alleles of a particular locus, depending on the repeat
structure of the microsatellite. Reported mutational rates
for the markers used in this study are: THO1-0%, FES-
0.117%, VWA-0.199%, and ACTBP2-0.684% per locus
per gamete per generation.20 However, gametic mutation
in an STR will not interfere with its usefulness in
chimerism analysis.
For sex-mismatched transplants the Y and X chromo-
some specific amelogenin PCR has a reported sensitivity of
one male cell in 106 female cells.21 A Y chromosome specific
band was detected post transplant in 11 female to male
transplants when the other markers suggested that the
chimerism was complete, confirming the higher sensitivity
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Figure 1 Schematic representation of informativeness of the STRs/VNTRs
used in our cohort. Adding a Genescan method along with b-globin gene and
amelogenin markers to the panel of screening informative marker has allowed
us to discriminate 99% of patient donor pairs in our cohort.
Table 3 Comparison of informativeness in HLA identical siblings
Markers Our study %
informativeness
North Indian
study (n¼ 42)
(%)
Thiede et al.18
(n¼ 203) %
informativeness
THO1 56 55 65*
VWA 50 62 67***
F13A1 20* 44 —
FES 44 55 —
ACTBP2 53 — 68**
*P40.01; **P40.001; ***P40.0001.
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of the amelogenin PCR. However, sensitivity of a marker
and its correlation with clinical outcome needs to be
evaluated further.
If either the patient or the donor has a unique band on
PAGE analysis, genescan can be used to evaluate chimer-
ism and this was useful in six patients, increasing the
informative value of the same STR markers from 95 to
98% in this study.
Quantification of the level of chimerism is necessary for
serial monitoring and this can be performed by newer
techniques like FISH, STR/VNTR genescan analysis and
real-time PCR. Although FISH has a high sensitivity of
0.1–0.001%, it can be used only for sex-mismatched
transplants. Recently Buno et al. have demonstrated that
STR-PCR is better than XY-FISH for quantifying
chimerism and is independent of the sex mismatch.22
Highly sensitive quantitative real-time PCR (detection
limit – 0.001–0.0001) has also been applied for monitoring
chimerism, however, the SNPs to be used and the clinical
significance of documenting mixed chimerism at a very low
level needs to be evaluated.23
Chimerism assessment with capillary electrophoresis by
fluorescence-based PCR amplification of STRs is currently
the most suitable method for post transplant chimerism
with a sensitivity of 1–5% and high accuracy24 but
formation of stutter peaks and preferential amplification
of the shorter allele are limitations. Highly specific STR
amplification by TD-PCR by Fundia et al.25 has further
improved the utility of di-nt STRs in post-BMT chimerism
analysis.
Short tandem repeat PCR and conventional PAGE
followed by capillary electrophoresis for quantification is
cost effective (d28–30 for the first post-BMT screening and
d8.4 for subsequent tests once the informative marker has
been found) when compared to commercial kits (range
d38–77). The average heterozygosity of all the markers used
in this study is similar in most populations (Table 4) and
therefore this algorithm of testing can be widely used for
chimerism analysis post-BMT.
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